- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 50.14M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 49.98M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 48.46M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$12.72M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$33M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $47.49M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $154.47M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $150.91M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $154.49M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $238.91M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $265.53M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $6.55M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $16.46M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $27.91M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $38.2M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $165.71M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $178.35M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $178.82M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $192.69M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.12 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.97 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.12 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.97 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $5.62M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $8.49M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$6.06M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$46.83M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$7.6M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$49.8M |
| Capex | Q1 2025 · Mar 31, 2024 | $153K |